FLI
Showing 1 - 25 of 74
Vaginosis, Bacterial Trial in Aversa (Logusgyn ovules, Logusgyn Lavander, Placebo)
Completed
- Vaginosis, Bacterial
- Logusgyn ovules
- +2 more
-
Aversa, Campania, ItalyOspedale San Giovanni Moscati
Dec 5, 2022
Ewing's Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in New York, Dallas (pbi-shRNA™ EWS/FLI1 Type 1 LPX)
Active, not recruiting
- Ewing's Sarcoma
- +6 more
- pbi-shRNA™ EWS/FLI1 Type 1 LPX
-
New York, New York
- +1 more
Mar 14, 2022
FLI Normative Study
Completed
- Hearing Loss
- Functional Listening Index
-
Milperra, New South Wales, AustraliaThe MARCS Institute Western Sydney University
Oct 27, 2021
NAFLD, Type 1 Diabetes, Cardiovascular Diseases Trial in Edegem (ultrasound, elastography, controlled attenuation parameter
Recruiting
- NAFLD
- +2 more
- ultrasound
- +5 more
-
Edegem, Antwerp, BelgiumAntwerp University Hospital
Mar 3, 2022
Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx Trial in Rotterdam (CRGD-ZW800-1)
Not yet recruiting
- Squamous Cell Carcinoma of the Larynx
- Squamous Cell Carcinoma of the Hypopharynx
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Feb 21, 2023
Novel Antidiabetic Medications and Their Effect on Liver
Completed
- Non-Alcoholic Fatty Liver Disease
- Liver Steatosis
- Empagliflozin
- +2 more
-
Athens, Attiki, Greece"Hippocration" General Hospital of Athens
Jul 13, 2023
Squamous Cell Carcinoma of the Head and Neck, Oral Cancer, Squamous Cell Carcinoma of the Oral Cavity Trial in Rotterdam
Not yet recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +2 more
-
Rotterdam, Zuid-Holland, NetherlandsErasmus University Medical Center
Mar 23, 2022
Ewing Sarcoma, Desmoplastic Small Round Cell Tumor, Pediatric Cancer Trial in Philadelphia (Lurbinectedin)
Not yet recruiting
- Ewing Sarcoma
- +3 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jun 27, 2023
Non-Alcoholic Fatty Liver Disease, Type2diabetes Trial in Karachi (Empagliflozin 10 MG, Pioglitazone 15mg, Metformin)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Type2diabetes
- Empagliflozin 10 MG
- +2 more
-
Karachi, Sindh, PakistanMedical ICU, Jinnah Postgraduate Medical Centre
Jul 11, 2023
Nonalcoholic Fatty Liver, Osteoporosis, Postmenopausal Trial (Denosumab, Alendronate Sodium)
Not yet recruiting
- Nonalcoholic Fatty Liver
- Osteoporosis, Postmenopausal
- Denosumab
- Alendronate Sodium
- (no location specified)
Aug 6, 2022
New Cytokine-based Dynamic Stratification Based on FLt3 Ligand
Recruiting
- Acute Myeloid Leukemia
- No intervention
-
Strasbourg, Bas-Rhin, France
- +24 more
Aug 25, 2021
Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)
Not yet recruiting
- Colon Cancer
- Immunotherapy
-
Chongqing, ChinaDaping hospital
Apr 16, 2023
Soy Milk vs Cow's Milk on Cardiometabolic Outcomes
Active, not recruiting
- Cardiovascular Diseases
- +3 more
- Soy milk
-
Toronto, Ontario, CanadaClinical Nutrition and Risk Factor Modification Centre, St. Mich
Nov 28, 2022
Non-Alcoholic Fatty Liver Disease Trial in Singapore (Lifestyle Advice, Diet Intervention, OCFA Meal-Based Diet-Intervention)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Lifestyle Advice
- +2 more
-
Singapore, SingaporeHuman Development Research Centre (Hdrc)
Feb 25, 2022
Visceral Obesity, Non-Alcoholic Fatty Liver Disease Trial in Reus (Multi-ingredient of L-histidine, L-serine, L-carnosine and
Not yet recruiting
- Visceral Obesity
- Non-Alcoholic Fatty Liver Disease
- Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine
- Placebo
-
Reus, SpainEurecat
Mar 28, 2023
Liver and Intrahepatic Bile Duct Carcinoma Trial in Houston (Clinical Evaluation, Laboratory Biomarker Analysis, Liver
Recruiting
- Liver and Intrahepatic Bile Duct Carcinoma
- Clinical Evaluation
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jun 7, 2022
Obesity, Inflammation Trial in Hellerup (Dapiglutide, Placebo)
Not yet recruiting
- Obesity
- Inflammation
- Dapiglutide
- Placebo
-
Hellerup, DenmarkCenter for Clinical Metabolic Research, Herlev-Gentofte Hospital
Mar 24, 2023
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Hepatic Steatosis Trial in Kyiv, Lviv (Probiotic lysate
Recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
- Probiotic lysate (postbiotic and metabiotc)
- Placebo
-
Kyiv, Ukraine
- +3 more
Mar 27, 2023
Population-based Study in Screening for Liver Fibrosis
Enrolling by invitation
- Liver Diseases
-
Zagreb, Croatia
- +31 more
Sep 15, 2022
Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)
Recruiting
- Ewing Sarcoma
- Ewing-Like Sarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022
Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)
Active, not recruiting
- Fatty Liver, Nonalcoholic
- Diabetes Mellitus, Type 2
-
Alexandria, EgyptAlexandria University.
Jan 14, 2022
NASH With Fibrosis Trial in Beijing
Not yet recruiting
- NASH With Fibrosis
-
Beijing, Beijing, ChinaBeijing Tsinghua Changgung Hospital
Nov 3, 2023
Sarcoma, Ewing Trial in China (TK216+Vincristin)
Not yet recruiting
- Sarcoma, Ewing
- TK216+Vincristin
-
Beijing, Beijing, China
- +7 more
Jul 25, 2022